TMITE
DEAD

Serial Number

97087375

Owner

Crossbow Therapeutics, Inc.

Attorney

Gwenn Roos

Filing Date

Oct 22, 2021

Add to watchlist:

No watchlists yet
View on USPTO

TMITE Trademark

Serial Number: 97087375

TMITE is a trademark filed by Crossbow Therapeutics, Inc. on October 22, 2021. The trademark is classified under Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Crossbow Therapeutics, Inc. (25 trademarks)

1030 Massachusetts Avenue, Suite 210
Cambridge, MA 02138

Entity Type: 03

Trademark Details

Filing Date

October 22, 2021

Registration Date

Not Registered

Published for Opposition

September 13, 2022

Goods & Services

Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research in the field of diagnosis and treatment of cancer and immunological diseases; Medical and scientific research information in the field of cancer and immunological diseases; Pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development in the field of cancer and immunological diseases; Scientific research for medical purposes in the area of cancerous diseases; Scientific research for medical purposes in the field of cancer and immunological diseases; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy

Filing History

ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
Mar 6, 2023 MAB5
ABANDONMENT - AFTER PUBLICATION
Mar 6, 2023 ABN5
TEAS EXPRESS ABANDONMENT RECEIVED
Mar 4, 2023 EXAR
EXTENSION OF TIME TO OPPOSE RECEIVED
Oct 13, 2022 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 13, 2022 NPUB
PUBLISHED FOR OPPOSITION
Sep 13, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 24, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 9, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 8, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 8, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 8, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 8, 2022 CNEA
ASSIGNED TO EXAMINER
Aug 1, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 8, 2021 NWOS
NEW APPLICATION ENTERED
Oct 26, 2021 NWAP